95 filings
Page 4 of 5
8-K
qv1vo3fl9cw55i65zli5
2 Apr 18
Novus Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
9yg3dq
12 Mar 18
Other Events
12:00am
8-K
3mpvi3 83qlzx1b
29 Nov 17
Results of Operations and Financial Condition
12:00am
8-K
ph5kzlw0 o5j69k
8 Nov 17
Novus Therapeutics Reports Third Quarter 2017 Results
12:00am
8-K
2tth8h coj2xfofp6u5v
6 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
zv5dv2w
29 Sep 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
v1cxrv58ctuj03bgbmq
22 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
aq7miko 0s5n
10 Aug 17
Novus Therapeutics Reports Second Quarter 2017 Results
12:00am
8-K/A
h00dyzroxzfxmt kr1
25 Jul 17
Index to Unaudited Interim Financial Statements
12:00am
8-K
z238hwx1uhmyhb 81w
10 Jul 17
Departure of Directors or Certain Officers
12:00am
8-K
tlto7 do6pv9
31 May 17
Departure of Directors or Certain Officers
12:00am
8-K
38pwq
15 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
yamcp0 e4ifz85
28 Apr 17
Other Events
12:00am
8-K
swpljd5veqtzgg7 ae3g
9 Mar 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
2e4r1p8bmaeszz r3ws
3 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
o8bhsnsl
22 Dec 16
Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement
12:00am
8-K
r2kwzi
12 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
8zh hkf01p64ow
22 Aug 16
Regulation FD Disclosure
12:00am
8-K
3vp3w yid
3 Aug 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
97dvbabhbtc8z3f7ox80
26 Jul 16
Results of Operations and Financial Condition
12:00am